Nureca Ltd.
ShareNURECA Competitor Analysis
| NURECA | POLYMED  | POLYPLEX | LAXMIDENTL | TARSONS | |
|---|---|---|---|---|---|
Overview | |||||
| Current price (₹) As on 30 Sept, 2025, 03:44 PM | 230.48 1.13% | 1,948.10 0.73% | 1,037.90 -0.05% | 325.20 1.93% | 305.15 -0.75% |
| Market cap (₹ Cr) | 230 | 19,739 | 3,258 | 1,787 | 1,624 |
Report Card | |||||
| Quality | |||||
| Growth | |||||
| Momentum | |||||
| Value | |||||
Past ReturnsAbsolute Returns Shown | |||||
| 1D | -0.19% | -1.3% | -1.24% | 0.68% | 0.07% |
| 1W | -3.33% | -0.97% | -4.33% | -6.19% | -0.66% |
| 1M | -5.09% | -7.26% | 2.61% | -6.51% | -1.4% |
| 3M | -19.98% | -13.02% | -14.27% | -26.56% | -22.3% |
| 6M | 7.76% | -13.86% | -13.09% | -28.33% | 1.86% |
| 1Y | -37.42% | -16.45% | -9.53% | -- | -30.68% |
| 5Y | -- | 321.76% | 48.33% | -- | -- |
Income StatementAnnual data as on 30 Sept 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Sales | 109.66 19.29% | 1,670 21.37% | 6,885 9.16% | 239.11 23.53% | 392.41 32.4% |
| OPM (%) | -6.18 37.95% | 25.74 3.08% | 9.97 74% | 17.27 41.79% | 27.11 -16.38% |
| PBT | 1.34 152.76% | 447.34 30.9% | 445.34 486.67% | 31.83 273.59% | 44.8 -26.28% |
PAT | 0.85 147.49% | 333.38 30.36% | 357.72 314.08% | 24.67 50.98% | 29.77 -30.18% |
| Net Profit Margin | 0.77 139.49% | 20.27 7.99% | 5.2 279.56% | 13.31 2.15% | 7.59 -47.26% |
| EPS | 0.85 147.49% | 33.41 24.15% | 66.64 453.03% | 5.78 -99.28% | 5.6 -30.09% |
Balance Sheet & Cash FlowAnnual data as on 30 Sept 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Net Worth | 194.29 0.61% | 2,766 88.16% | 3,763 7.18% | 208.54 576.2% | 630.21 2.83% |
| Total Assets | 209.98 2.34% | 3,192 71.71% | 7,998 7.63% | 284.67 111.62% | 1,080 11.09% |
| Total Outside Liabilities | 15.69 30.21% | 426.79 9.82% | 4,235 8.04% | 76.13 -26.57% | 449.83 25.19% |
| Cash from Operating Activity | -19.08 -604.06% | 240.42 -9.64% | 438.03 -3.78% | 43.83 437.79% | 114.24 11.23% |
| Cash from Investment Activity | 8.44 -51.99% | -1,194 -395.56% | -473.06 40.6% | -29.24 -102.49% | -145.49 48.94% |
| Cash from Financing Activity | -0.17 86.92% | 950.51 4817.17% | -37.54 75.34% | 110.64 11306.19% | 38.95 -71.28% |
| Net Cash Flow | -10.82 -179.79% | -3.35 -167.13% | -63.87 87.26% | 125.27 2381.79% | 8.02 117.18% |
RatiosAnnual data as on 30 Sept 2025. | |||||
| PB | 1.08 | 8.21 | 1.02 | 11.70 | 2.55 |
| PE | 272.43 | 58.30 | 15.57 | 56.26 | 54.54 |
| ROE (%) | 0.44 | 15.74 | 9.84 | 20.61 | 4.79 |
| Dividend Yield (%) | 0 | 0.18 | 1.30 | 0 | 0.66 |
| ROCE (%) | 1.31 | 20.04 | 11.08 | 20.62 | 7.02 |
